pain management part 2 use of adjuvants john mulder, md, faahpm vice president of medical services...

22
Pain Management Part 2 Use of Adjuvants John Mulder, MD, FAAHPM Vice President of Medical Services Faith Hospice Director, GR MEP Palliative Medicine Fellowship Program

Upload: ilene-reeves

Post on 16-Dec-2015

217 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: Pain Management Part 2 Use of Adjuvants John Mulder, MD, FAAHPM Vice President of Medical Services Faith Hospice Director, GR MEP Palliative Medicine Fellowship

Pain Management Part 2Use of Adjuvants

John Mulder, MD, FAAHPMVice President of Medical Services

Faith Hospice

Director, GR MEP Palliative Medicine Fellowship Program

Page 2: Pain Management Part 2 Use of Adjuvants John Mulder, MD, FAAHPM Vice President of Medical Services Faith Hospice Director, GR MEP Palliative Medicine Fellowship

Coanalgesic Drugs (Adjuvant Therapy)Definition: Drugs which enhance analgesic efficacy of opioids, treat concurrent symptoms that exacerbate pain, or produce independent analgesia for specific types of pain.

• Early use optimizes comfort and function by preventing or reducing side effects of higher doses of opioids

Page 3: Pain Management Part 2 Use of Adjuvants John Mulder, MD, FAAHPM Vice President of Medical Services Faith Hospice Director, GR MEP Palliative Medicine Fellowship

Coanalgesic Drugs (Adjuvant Therapy)Most amenable cancer pain syndromes• Bone metastases• Neuropathic pain • Visceral distention

Most commonly used coanalgesic drugs• NSAIDs• Corticosteroids• Antidepressants• Anticonvulsants

Page 4: Pain Management Part 2 Use of Adjuvants John Mulder, MD, FAAHPM Vice President of Medical Services Faith Hospice Director, GR MEP Palliative Medicine Fellowship

Bone Metastases - Adjuvants

• NSAIDs

• Steroids

• Decadron 4mg BID, titrate

• Bisphosphonates

• Zometa, Aredia

• Radioisotopes

Page 5: Pain Management Part 2 Use of Adjuvants John Mulder, MD, FAAHPM Vice President of Medical Services Faith Hospice Director, GR MEP Palliative Medicine Fellowship

Neuropatic Pain – Adjuvants

• Tricyclic antidepressants

• Anticonvulsants

• Steroids

Page 6: Pain Management Part 2 Use of Adjuvants John Mulder, MD, FAAHPM Vice President of Medical Services Faith Hospice Director, GR MEP Palliative Medicine Fellowship

• NSAIDs

• Antidepressants

• TCA - Elavil, gold standard; desipramine

• SSRI - Paxil only one shown effective thus far; Serzone, Effexor

promising

• Psychostimulants - dietary caffeine, Ritalin, amphetamines

Alternative/Adjuvant Medications

Page 7: Pain Management Part 2 Use of Adjuvants John Mulder, MD, FAAHPM Vice President of Medical Services Faith Hospice Director, GR MEP Palliative Medicine Fellowship

• Neuroleptics

• Benzodiazapines (watch for sedation)

• Anticonvulsants - especially for neurogenic pain (Neurontin)

• Baclofen

Alternative/Adjuvant Medications

Page 8: Pain Management Part 2 Use of Adjuvants John Mulder, MD, FAAHPM Vice President of Medical Services Faith Hospice Director, GR MEP Palliative Medicine Fellowship

• Steroids - high dose, short term/low-dose, long term

• Antihistamines (Benedryl, Vistaril)

• Alpha-2-adrenergic stimulants (Clonidine)

• Cannabanoids

Alternative/Adjuvant Medications

Page 9: Pain Management Part 2 Use of Adjuvants John Mulder, MD, FAAHPM Vice President of Medical Services Faith Hospice Director, GR MEP Palliative Medicine Fellowship

Alternative/Adjuvant Medications

• Capsaicin

• Colchicine

• Thalidomide

• Ketamine

• Lidocaine

• Dextromethorphan - (no guaifenesin or alcohol) - 30 mg BID - 1 g/d (400 - 600 mg/d usual )

Page 10: Pain Management Part 2 Use of Adjuvants John Mulder, MD, FAAHPM Vice President of Medical Services Faith Hospice Director, GR MEP Palliative Medicine Fellowship

Narcotic Resistant Pains• Headaches

• Muscle Spasm

• Tenesmoid (Bowel / Bladder)

• Incident to movement

• Decubitus

• Deafferentation

Page 11: Pain Management Part 2 Use of Adjuvants John Mulder, MD, FAAHPM Vice President of Medical Services Faith Hospice Director, GR MEP Palliative Medicine Fellowship

Deafferention Pain• Type I Complex Regional Pain Syndrome

A syndrome characterized by severe burning pain in an extremity accompanied by sudomotor, vasomotor, and trophic changes in bone without an associated specific nerve injury. ...

• Complex Regional Pain Syndromes

Conditions characterized by pain involving an extremity or other body region, HYPERESTHESIA, and localized autonomic dysfunction following injury to soft tissue or nerve. The pain ...

• Reflex Sympathetic Dystrophy Syndrome

A syndrome characterized by severe burning pain in an extremity accompanied by sudomotor, vasomotor, and trophic changes in bone without an associated specific nerve injury. ...

Page 12: Pain Management Part 2 Use of Adjuvants John Mulder, MD, FAAHPM Vice President of Medical Services Faith Hospice Director, GR MEP Palliative Medicine Fellowship

• OMM

• Acupuncture

• Acupressure

• Massage Therapy

• Music Therapy

• Hypnosis

• Relaxation

Non-pharmacologic Interventions

Page 13: Pain Management Part 2 Use of Adjuvants John Mulder, MD, FAAHPM Vice President of Medical Services Faith Hospice Director, GR MEP Palliative Medicine Fellowship
Page 14: Pain Management Part 2 Use of Adjuvants John Mulder, MD, FAAHPM Vice President of Medical Services Faith Hospice Director, GR MEP Palliative Medicine Fellowship

Unwarranted / Exaggerated Fears

• Respiratory Depression

• Addiction

• Rapid Tolerance

• Regulatory Reprisal

Page 15: Pain Management Part 2 Use of Adjuvants John Mulder, MD, FAAHPM Vice President of Medical Services Faith Hospice Director, GR MEP Palliative Medicine Fellowship

Opiate Side Effects: Constipation

– Most common side effect - expected– Mediated spinally and in GI tract– Decreased peristalsis & decreased intestinal

secretions– Tolerance does not readily occur– Treat with peristaltic agent and softeners -

prophylactically

Page 16: Pain Management Part 2 Use of Adjuvants John Mulder, MD, FAAHPM Vice President of Medical Services Faith Hospice Director, GR MEP Palliative Medicine Fellowship

Opiate Side Effects: Pruritis

– Caused by opioid induced histamine release– Tolerance generally develops quickly– Difficult cases may require a change in opioid– Usually treated with transient use of

antihistamines

Page 17: Pain Management Part 2 Use of Adjuvants John Mulder, MD, FAAHPM Vice President of Medical Services Faith Hospice Director, GR MEP Palliative Medicine Fellowship

Opiate Side Effects: Somnolence / Sedation

– Common, but tolerance typically develops within a few days

– Sedation varies with opioid and dosing schedule– Additive effects with other cerebral depressants– Decrease or discontinue other cerebral depressants– Concurrent use of Dextroamphetamine or

Methylphenidate is helpful, but tachyphylaxis is common

Page 18: Pain Management Part 2 Use of Adjuvants John Mulder, MD, FAAHPM Vice President of Medical Services Faith Hospice Director, GR MEP Palliative Medicine Fellowship

Opiate Side Effects: Hallucinations / Confusion

– Less common, but may occur especially in older patients

– Often an indication of excess dosing– Try dose reduction or different opioid

Page 19: Pain Management Part 2 Use of Adjuvants John Mulder, MD, FAAHPM Vice President of Medical Services Faith Hospice Director, GR MEP Palliative Medicine Fellowship

Opiate Side Effects: Nausea / Vomiting

– Occurs in 50 – 65% of patients on oral morphine

– Varies with drug and route– Usually easy to control, occasionally severe and

difficult to control

Page 20: Pain Management Part 2 Use of Adjuvants John Mulder, MD, FAAHPM Vice President of Medical Services Faith Hospice Director, GR MEP Palliative Medicine Fellowship

Opiate Side Effects: Urinary Retention

– Opioids increase smooth muscle tone (sphincter)

– May also cause bladder spasms– Try changing opioids or insertion of catheter

Page 21: Pain Management Part 2 Use of Adjuvants John Mulder, MD, FAAHPM Vice President of Medical Services Faith Hospice Director, GR MEP Palliative Medicine Fellowship

Opiate Side Effects: Myoclonus

– Can occur with all opioids– Typically due to high doses and/or dehydration– Long half-life metabolites are typically

implicated– Reduce dose, change opioids, change routes

and/or hydrate patient

Page 22: Pain Management Part 2 Use of Adjuvants John Mulder, MD, FAAHPM Vice President of Medical Services Faith Hospice Director, GR MEP Palliative Medicine Fellowship

Opiate Side Effects: Respiratory Depression

– Cause of death in opioid overdose– Tolerance develops rapidly– Rarely a concern with appropriate dose

escalations– If accidental overdose occurs in a patient

chronically receiving opioids, dilute Naloxone 1:10 and titrate very carefully to reverse respiratory depression without precipitating withdrawal or reversing analgesia